Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92410949 | 9241094 | 9 | F | 201212 | 20160815 | 20130419 | 20160818 | EXP | CA-AMGEN-CANSP2013008286 | AMGEN | 56.00 | YR | A | F | Y | 0.00000 | 20160818 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92410949 | 9241094 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, QWK | 1032906 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 92410949 | 9241094 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | 40 MG, Q2WK | 0 | 40 | MG | QOW | |||||||
| 92410949 | 9241094 | 3 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | 1 G, UNK | 0 | 1 | G | ||||||||
| 92410949 | 9241094 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 92410949 | 9241094 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 92410949 | 9241094 | 6 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 92410949 | 9241094 | 7 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 92410949 | 9241094 | 8 | SS | ARAVA | LEFLUNOMIDE | 1 | Oral | 20 MG, OD | 0 | 20 | MG | ||||||||
| 92410949 | 9241094 | 9 | C | GOLD | GOLD | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92410949 | 9241094 | 1 | Rheumatoid arthritis |
| 92410949 | 9241094 | 2 | Rheumatoid arthritis |
| 92410949 | 9241094 | 3 | Rheumatoid arthritis |
| 92410949 | 9241094 | 4 | Product used for unknown indication |
| 92410949 | 9241094 | 5 | Rheumatoid arthritis |
| 92410949 | 9241094 | 6 | Rheumatoid arthritis |
| 92410949 | 9241094 | 7 | Rheumatoid arthritis |
| 92410949 | 9241094 | 8 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92410949 | 9241094 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92410949 | 9241094 | Abdominal discomfort | |
| 92410949 | 9241094 | Adverse drug reaction | |
| 92410949 | 9241094 | Back pain | |
| 92410949 | 9241094 | Blood pressure increased | |
| 92410949 | 9241094 | Contusion | |
| 92410949 | 9241094 | Drug ineffective | |
| 92410949 | 9241094 | Dysphagia | |
| 92410949 | 9241094 | Femur fracture | |
| 92410949 | 9241094 | Gait disturbance | |
| 92410949 | 9241094 | Haemorrhage | |
| 92410949 | 9241094 | Hypersensitivity | |
| 92410949 | 9241094 | Injection site bruising | |
| 92410949 | 9241094 | Injection site erythema | |
| 92410949 | 9241094 | Injection site hypersensitivity | |
| 92410949 | 9241094 | Intervertebral disc degeneration | |
| 92410949 | 9241094 | Oedema peripheral | |
| 92410949 | 9241094 | Osteoarthritis | |
| 92410949 | 9241094 | Pain | |
| 92410949 | 9241094 | Pruritus generalised | |
| 92410949 | 9241094 | Rash | |
| 92410949 | 9241094 | Spinal disorder | |
| 92410949 | 9241094 | Spinal operation | |
| 92410949 | 9241094 | Swelling | |
| 92410949 | 9241094 | Therapy non-responder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92410949 | 9241094 | 1 | 20121108 | 0 | ||
| 92410949 | 9241094 | 2 | 20130506 | 20131008 | 0 | |
| 92410949 | 9241094 | 3 | 20131022 | 20140507 | 0 |